Jan 09, 2024 / 10:15PM GMT
Jessica Macomber Fye - JPMorgan Chase & Co, Research Division - Analyst
Great. Good afternoon, everyone. My name is Jess Fye. I'm a senior biotech analyst at JPMorgan and we're continuing the healthcare conference today with Legend Biotech. I'm joined on stage by the company's CEO, Ying Huang. And he's going to give a presentation on the business and then we're going to go into some Q&A. Anyone in the room, you can raise your hand to ask a question, someone will bring you a microphone, or if you have questions you want to submit on the portal, you can do that too.
So with that, let me pass it over to Ying.
Ying Huang - Legend Biotech Corporation - CEO & Director
Thank you, Jess, and I want to also thank JPMorgan for inviting Legend for this conference.
So with that, I'm going to give a very brief overview of the company's operation and then we'll go into Q&A with Jess and anyone, feel free to post questions from the room.
So first, standard disclaimer. We are a public trading company and we are going to make some
Legend Biotech Corp at JPMorgan Healthcare Conference Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |

30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 

4.6 out of 5
Trustpilot
